跳至主要内容
临床试验/NCT05226351
NCT05226351已完成不适用

Activation of the Endocannabinoid System and Cognition (Effekte Einer Akuten Aktivierung Des Cannabinoid-Systems Auf Kognitive Funktionen)

Charite University, Berlin, Germany2 个研究点 分布在 1 个国家目标入组 192 人开始时间: 2022年3月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
192
试验地点
2
主要终点
extinction learning

研究概览

简要总结

Recent data suggest that the cannabinoid-system is involved in stress regulation and posttraumatic stress disorder (PTSD). Low endocannabinoid signaling has been found in PTSD patients and might even present a precondition to develop PTSD after trauma. The aim of the current project is to investigate the impact of an activation of the cannabinoid system with an exogenous cannabinoid (dronabinol, i.e., delta-9-tetrahydrocannabinol) on fear conditioning.

详细描述

Recent data suggest that the cannabinoid-system is involved in stress regulation and posttraumatic stress disorder (PTSD). Low endocannabinoid signaling has been found in PTSD patients and might even present a precondition to develop PTSD after trauma. In consequence, increased endocannabinoid signaling during acquisition and consolidation of traumatic events might be a promising approach to prevent the development of PTSD. The aim of the current project is to investigate the impact of an activation of the cannabinoid system with an exogenous cannabinoid (dronabinol, i.e., delta-9-tetrahydrocannabinol) on tfear conditioning in patients with PTSD and healthy controls.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Factorial
主要目的
Other
盲法
Double (Participant, Investigator)

盲法说明

blinding

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • PTSD criteria fullfilled (patients only)

排除标准

  • All cases of physical illnesses and intake of medication (except oral contraceptives) (healthy controls only) will be excluded.
  • Pregnant and lactating individuals will also be excluded. Participants with a positive urinary cannabinoid test (Cannabis 20 Pipettier-Drogenschnelltest (Urin), Diagnostik Nord GmbH) will also be excluded.
  • psychiatric disorder according to DSM-5 (healthy controls only)

研究组 & 干预措施

Dronabinol PTSD

Active Comparator

Donabinol before cognitve testing - PTSD patients

干预措施: Dronabinol 2.5 mg (Drug)

Dronabinol healthy controls

Active Comparator

Donabinol before cognitve testing - healthy controls

干预措施: Dronabinol 2.5 mg (Drug)

Placebo PTSD

Placebo Comparator

Placebo before cognitve testing - PTSD patients

干预措施: Placebo (Drug)

Placebo healthy controls

Placebo Comparator

Placebo before cognitve testing - healthy controls

干预措施: Placebo (Drug)

结局指标

主要结局

extinction learning

时间窗: 30 minutes

extinction learning in fear conditioning paradigm: skin conductance reaction

次要结局

  • selective attention(10 minutes)
  • empathy(15 minutes)
  • Probabilistic Reversal Learning Task(15 minutes)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Stefan Roepke

Prof. Dr. Stefan Röpke

Charite University, Berlin, Germany

研究点 (2)

Loading locations...

相似试验